中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2015年
12期
111-112
,共2页
氯吡格雷%阿司匹林%老年冠心病
氯吡格雷%阿司匹林%老年冠心病
록필격뢰%아사필림%노년관심병
Clopidogrel%Aspirin%Senile Coronary Heart Disease
目的:探讨氯吡格雷与阿司匹林治疗老年冠心病的临床疗效。方法整群选取2012年1月-2013年1月期间该院收治的92例老年冠心病患者为研究对象,根据治疗方式的不同分为两组,对照组患者给予阿司匹林治疗,观察组患者给予氯吡格雷治疗,比较两组患者的治疗效果。结果观察组患者的治疗效果明显高于对照组患者,P<0.05,观察组患者治疗后的PT、APTT指标明显优于对照组患者,且不良反应也比对照组少,P<0.05,差异具有统计学意义。结论氯吡格雷与阿司匹林治疗老年冠心病的临床疗效相比,前者的治疗效果更加显著,可以改善患者的相关指标,不良反应较少,具有较高的临床使用价值。
目的:探討氯吡格雷與阿司匹林治療老年冠心病的臨床療效。方法整群選取2012年1月-2013年1月期間該院收治的92例老年冠心病患者為研究對象,根據治療方式的不同分為兩組,對照組患者給予阿司匹林治療,觀察組患者給予氯吡格雷治療,比較兩組患者的治療效果。結果觀察組患者的治療效果明顯高于對照組患者,P<0.05,觀察組患者治療後的PT、APTT指標明顯優于對照組患者,且不良反應也比對照組少,P<0.05,差異具有統計學意義。結論氯吡格雷與阿司匹林治療老年冠心病的臨床療效相比,前者的治療效果更加顯著,可以改善患者的相關指標,不良反應較少,具有較高的臨床使用價值。
목적:탐토록필격뢰여아사필림치료노년관심병적림상료효。방법정군선취2012년1월-2013년1월기간해원수치적92례노년관심병환자위연구대상,근거치료방식적불동분위량조,대조조환자급여아사필림치료,관찰조환자급여록필격뢰치료,비교량조환자적치료효과。결과관찰조환자적치료효과명현고우대조조환자,P<0.05,관찰조환자치료후적PT、APTT지표명현우우대조조환자,차불량반응야비대조조소,P<0.05,차이구유통계학의의。결론록필격뢰여아사필림치료노년관심병적림상료효상비,전자적치료효과경가현저,가이개선환자적상관지표,불량반응교소,구유교고적림상사용개치。
Objective To investigate the clinical efficacy of clopidogrel and aspirin in the treatment of senile coronary heart dis-ease. Methods From January 2012 to January 2013 92 cases of senile coronary heart disease patients in our hospital as the re-search object, according to the different treatment methods into two groups, patients in control group were treated with aspirin treatment, observation group were treated with clopidogrel treatment, compared two groups of patients with curative effect. Results The patients in the observation group treatment effect was significantly higher than that of patients in the control group, P< 0.05, patients in the observation group after treatment PT, APTT index was significantly better than the control group of patients, and the adverse reactions are less than the control group, P< 0.05, with significant difference. Conclusion Compared the clinical efficacy of clopidogrel and aspirin in treatment of senile coronary heart disease, the former treatment effect is more significant, correlation index can improve the patients, less adverse reaction, has high clinical value.